Blood Banking and Blood Products: Market Research Report

January 2018 | 617 pages | ID: B35D2616800EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Group/Types: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022.

Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs.

The report profiles 209 companies including many key and niche players such as -

• AABB
• Americas Blood Centers
• American Red Cross
• Canadian Blood Services
• Japan Red Cross Society

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Prelude
Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
Safety and Availability: The Core Issues

Table 1. Prevalence of Major Transfusion-transmitted Infections by Economic Group (2016): Percentage of HIV, HBV and HCV in High Income, Middle Income and Low Income Countries (includes corresponding Graph/Chart)

Current and Future Analysis
Analysis of World Blood Banking & Blood Products by Value Sales
World Blood Components and Plasma Market Analysis

Table 2. World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan and Rest of World Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 3. World 8-Year Perspective for Blood Components and Plasma by Region/ Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart)

Red Blood Cells – A Key Blood Component

Table 4. World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 5. World 8-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2015, 2017 & 2022 (includes corresponding raph/Chart)

2. MARKET TRENDS & ISSUES

Blood Plasma Demand Exceeds Supply: Self-Sufficiency is the New Mantra

Table 6. Worldwide Market for Plasma Derivative Products by Product Type (2014): Percentage Breakdown of Revenues for A1PI, Albumin, Coagulation Factor, Hyperimmunes, IVIG, Plasma Derived Factor VIII, Prothrombin Complex Concentrate, and Others (includes corresponding Graph/Chart)

Higher Plasma Center Numbers Key to Secure Raw Material Supply, Costs Remain A Bottleneck

Table 7. Number of Plasma Centers in Operation in the US for Leading Players (includes corresponding Graph/Chart)

Platelet Rich Plasma Therapy Market Scales New Heights
Evolution in Plasma Collection Technologies – Current Achievements and Way Ahead
Demand for Plasma Derivatives on the Rise
Immunoglobulins to See Steady Growth

Table 8. Global Immunoglobulins Market by Segment (2017 & 2022): Percentage Breakdown of Market Value for Intravenous IG, Hyperimmunes and Subcutaneous IG (includes corresponding Graph/Chart)

Table 9. World IVIG Consumption by Geographic Region (2016): Annual Consumption in Kilograms Per Million People for North America, Europe and Rest of World (includes corresponding Graph/Chart)

Table 10. World Market for Immunoglobulins by Indication (2016): Percentage Breakdown of Market Value for CIPD< PI, Off-Label and Others (includes corresponding Graph/Chart)

Increasing Awareness of PID and CIPD Disorders to Drive IVIg Market
Indications Addressed by Major Global IVIg Manufacturers

Table 11. Comparative Costs between Plasma Protein Therapies and Artificially Synthesized Pharmaceuticals (includes corresponding Graph/Chart)

Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg Therapy

Table 12. Worldwide Home Healthcare Services Market by Type of Service (2015E & 2020P): Percentage Breakdown of Service Revenues for Infusion Therapy Services, Rehabilitation Services, Respiratory Therapy Services, Telemetry, and Unskilled Homecare (includes corresponding Graph/Chart)

Unsuccessful Clinical Trials for Alzheimer’s a major Setback for IVIg Market
New Indications to Drive Demand for Albumin

Table 13. World Albumin Consumption by Geography (2016): Annual Consumption in Grams per Thousand People for Leading Ten Countries (includes corresponding Graph/Chart)

Low Awareness Affects Apha1 Market
Recombinants Lead FVIII Market
Rising Incidence of Cancer Drives Demand for Apheresis Systems
PrIME: An Innovative High-Yield Process to Address Supply Dearth
Present State of Plasma Fractionating Industry
Plasma Fractionation Industry Concentrated in Developed Countries
PrIME Tackles the Issue of Currently Unprocessable Plasma
Industry Grappling with Blood Safety & Availability Issues
New Infections – A Continuous Threat
Synthetic Substitutes to Bridge Demand-Supply Gap in Blood
Autologous Transfusion Gearing up for High Growth
Out-of-Hospital Transfusions: An Emerging Phenomenon
Automation Tapping into Blood Market
Automation in Pre-Transfusion Diagnostics
Penetration of Automated Equipment in the Plasma Market
The Red Blood Cell Collection Opportunity
Robots in Blood Banking
Automated Blood Processing Systems in Open Heart Surgeries
Automated Systems in Cancer
Cerus’ INTERCEPT Blood System Set to See Wider Adoption
Pooling: Economical HIV Testing
Ballooning Global Geriatric Populace to Drive Demand for Blood Products

Table 14. Elderly Population (65+ Years) as a Percentage of the Total Population: 2014 & 2025 (includes corresponding Graph/Chart)

Table 15. Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)

Improving Healthcare Expenditure to Foster Growth of Blood Banking Sector

Table 16. Healthcare Spending as % of GDP by Region (2016E) (includes corresponding Graph/Chart)

Table 17. Global Intravenous Immunoglobulin Consumption in Kilograms per Million Residents for Select Countries (includes corresponding Graph/Chart)

3. COMPETITIVE LANDSCAPE

Leaders in Global Blood Plasma Ramp Up Market Share

Table 18. Leading Players in the Global Plasma Market (2016): Percentage Breakdown of Market Value for CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart)

Grifols – A Fast Emerging Player

Table 19. Plasma Fractionation Production Capacity of Grifols by Location: 2011 & 2015 (In Million Liters) (includes corresponding Graph/Chart)

Table 20. Leading Players in Plasma Fractionation by Capacity (2017 & 2022): Percentage Breakdown of Annual Capacity for CSL, Grifols, Kedrion, Octapharma, Shire and Others (includes corresponding Graph/Chart)

Grifols Loses Grip on IG Market, Pins Hopes on New Product
IVIg – A Highly Consolidated Market

Table 21. Leading Players in the Global Immunoglobulin Market (2016E): Percentage Breakdown of Market Value for CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart)

Table 22. Global Market for Immunoglobulin (IVIg and SCIg) by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)

Table 23. Global Subcutaneous Immunoglobulin Market by Leading Player (2014): Percentage Market Share Breakdown of Revenue for Baxter, CSL, and Grifols (includes corresponding Graph/Chart)

Big Three Corner Majority of Blood Collection Systems Market

Table 24. Global Whole Blood Collection Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, MacoPharma, Terumo, WEGO, and Others (includes corresponding Graph/Chart)

Table 25. Global Apheresis Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)

Other Key Statistics

Table 26. Leading Players in the Global Albumin Market (2016E): Percentage Breakdown of Market Value for CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart)

Table 27. Leading Players in the Global Alpha1 Market (2016E): Percentage Breakdown of Market Value for CSL, Grifols and Others (includes corresponding Graph/Chart)

Table 28. Leading Players in the Global Plasma Derived FVIII Market (2016E): Percentage Breakdown of Market Value for Biotest, CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart)

4. PRODUCT OVERVIEW

5. BLOOD COLLECTION METHODS

Banking the Natural Blood Resources
Blood Banks
Blood Banking
Blood Transfusion
Role of Blood Banks
Blood Donor: The Epicenter of the Process
Eligibility Criteria for the Donor
The Basics of Blood Donation – Myths & Facts

Table 31. Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/ Agency (includes corresponding Graph/Chart)

Table 32. Percentage Breakdown of Apheresis and Whole Blood Donations by Country (includes corresponding Graph/Chart)

Collection Methods
Blood Donation: The Process
Blood Salvaging
Blood Collection Centers
Blood Processing
The Costs
History of Blood Banking

6. THE DYNAMIC LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS

Blood Transfusion: A Backdrop
Massive Transfusion
Complications and Risks Due to Transfusion
Circulatory Overload
Graft Versus Host Disease (GVHD)
Hemolytic Transfusion Reactions
Iron Overload
Bacterial Contamination
Thrombophlebitis
Allergic Reactions
Air Embolism
Hyperkalaemia
Changing Role of Blood Banking Technology

7. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES

Cross Matching
Blood Donor/Recipient Screening
Blood Typing
Leukoreduction
Leukocyte Reduction Specification Standards/Filters
Coombs Test

8. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY

Bloodless Surgery
Therapeutic Apheresis
Plasmapheresis
Plateletpheresis
Leukapheresis
Volume Expanders
Colloids
Crystalloids
Blood Growth Factor Therapies – Newer Alternatives to Transfusion

9. PRODUCT APPROVALS/LAUNCHES

Biotest Secures EC Clearance for Vihuma
Roche Launches cobas m 511 Haematology Analyser
Abbott Obtains CE Mark for Alinity s Blood and Plasma Screening Device
Bio-Rad Secures FDA Clearance for New Blood Typing Instrument and Regents
Immucor Gets CE Mark for NEO Iris Automated Transfusion Instrument
Immucor’s PreciseType HEA Test Obtains FDA Approval
Fresenius Kabi Obtains FDA Approval for Aurora Xi Plasmapheresis System
BD Secures FDA Clearance for BD Barricor Plasma Blood Collection Tube
Cerus Gains Health Canada’s Approval for INTERCEPT System
FDA Clears BD’s New Plastic Blood Culture Bottle
FDA Approves Cerus’ INTERCEPT Blood System
BD Obtains CE Mark for Vacutainer Barricor Tube
BD Secures FDA and EU Clearance for BD Vacutainer UltraTouch Blood Collection Set
Roche Expands Blood Screening Solution Portfolio with New Offering
Roche Receives USFDA Approval for cobas TaqScreen MPX Test v2. 0 for HIV, HCV, and HBV Tests
Affinity Biologicals Unveils Factor VIII Deficient, Factor IX Deficient Plasmas

10. RECENT INDUSTRY ACTIVITY

Biotest to Sell Select US Therapy Business Assets to ADMA
Kedrion Biopharma Expands into Russia
Hologic to Sell Blood Screening Business to Grifols
China Biologic Products Gets CFDA Clearance for Antithrombin III Clinical Trial
China Biologic Receives CFDA Clearance for Human Trials on Human Coagulation Factor IX
Terumo Inks Distribution Agreement with B Medical Systems
Creat Group Takes Over Bio Products
Terumo Receives Initial Funding for FDP Product from US Government
Shire Takes Over Baxalta
LFB American Plasma and ImmunoTek BioCenters Ink Agreement
Grifols Expands Plasma Therapies’ Production Capacity
KEDPlasma Acquires Two Plasma Collection Centers in the US
Cerus and LifeShare Blood Centers Ink Purchase Agreement for INTERCEPT
Cerus Inks Production Deal with Fresenius Kabi for INTERCEPT Blood System
Baxter Spins Off Biopharmaceutical Business into Baxalta (US)
Cerus and SunCoast Blood Bank Ink Deal for INTERCEPT Blood System
Cerus Corporation Inks Purchase Agreement with Karolinska University Hospital
Cerus Corporation Signs Purchase Agreement with Blood Bank of Delmarva
Canadian Blood Services Closes 3 Permanent Clinics, Terminates Bloodmobile Program
Roche Releases Elecsys HTLV-I/II Immunoassay
China Biologic Products Purchases Additional Stake in Guizhou Taibang Biological Products
Community Blood Center Merges with New York Blood Center
Cerus Corp. Partners with Kawasumi Laboratories for Developing Intercept Platelets Kits
Vascular Solutions Collaborates with US AMMDA to Develop Plasma Products for Treating Hemorrhage
The San Diego Blood Bank Collaborates with Clinical and Translational Research Institute
AABB Collaborates with AATM for Promoting Blood and Cellular Therapies Standards in Asia
bioCSL Partners with Immucor for Distributing Transfusion Technology in Australia and New Zealand
PrIME Biologics Opens Plasma Fractionation Plant in Singapore

11. FOCUS ON SELECT PLAYERS

Leading Blood Banks
AABB (USA)
America’s Blood Centers (USA)
American Red Cross (USA)
Canadian Blood Services (Canada)
Japan Red Cross Society (Japan)
New York Blood Center (USA)
Sanquin Blood Supply Foundation (The Netherlands)
Leading Players in Blood Bank Technology and Supplies
Abbott Laboratories (USA)
Beckman Coulter, Inc. (USA)
Becton, Dickinson and Company (USA)
bioMérieux SA (France)
Bio-Rad Laboratories, Inc. (USA)
Cerus Corporation (USA)
CSL Behring LLC (USA)
Fresenius Kabi AG (Germany)
Fenwal Inc. (USA)
Haemonetics Corporation (USA)
Immucor Inc. (USA)
Kawasumi Laboratories, Inc. (Japan)
MacoPharma SA (France)
Ortho-Clinical Diagnostics, Inc. (USA)
Terumo BCT Inc. (USA)
Leading Players in Plasma Fractionation
Beijing Tiantan Biological Products Co., Ltd. (China)
Bharat Serums and Vaccines Ltd. (India)
Bio Products Laboratory Ltd. (UK)
Biotest AG (Germany)
China Biologic Products, Inc. (China)
Grifols S. A. (Spain)
Huanlan Biological Engineering Inc. (China)
Kedrion S. p. A. (Italy)
LFB Group (France)
Octapharma AG (Switzerland)
Shanghai RAAS Blood Products Co., Ltd. (China)
Shire plc (Ireland)
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)

12. GLOBAL MARKET PERSPECTIVE

Table 34. World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 35. World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 36. World 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

Blood Banking and Blood Products Market by Product Group/Type

Table 37. World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 38. World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 39. World 14-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

Table 40. World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 41. World Historic Review for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 42. World 14-Year Perspective for Blood Components and Plasma Products by Product Type - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

Table 43. World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 44. World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 45. World 14-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

Table 46. World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 47. World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 48. World 14-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

Table 49. World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 50. World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 51. World 14-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Current and Future Analysis
Demand for Blood Transfusion Wanes

Table 52. US Blood and Organ Banks by Leading Players (2014): Percentage Share Breakdown of Revenues for American Red Cross, Baxter International Inc., Blood Systems, Musculoskeletal Transplant Foundation, New York Blood Center, and Others (includes corresponding Graph/Chart)

Table 53. US Blood Banking Market by Leading Suppliers (2015): Percentage Breakdown of Unit Volumes for American Red Cross, Blood Centers of America, and Others (includes corresponding Graph/Chart)

Table 54. American Red Cross Dominates US Blood Platelet Production (2014): Percentage Share Breakdown of Production Volume for American Red Cross, and Others (includes corresponding Graph/Chart)

Blood Collection Economy Treads a Tightrope
Lower Blood Prices Become the Order of the Day
Aging Baby-Boomer Demography: A Key Market Driver

Table 55. North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Favorable Reimbursement and High Usage Make US the Largest Consumer of Immunoglobulins Worldwide
US Blood Collection & Supply Profile

Table 56. Number of Plasma Collection Centers in the US: 2011-2015 (includes corresponding Graph/Chart)

Table 57. US Plasma Collections for Years 2009, 2012 & 2015 (In Millions) (includes corresponding Graph/Chart)

Blood Group Distribution

Table 58. US Market for Blood Banking and Blood Products: Percentage Breakup of Blood Group by Rh Factor (includes corresponding Graph/Chart)

Table 59. Percentage Breakup of Rh Blood Types in the US by Racial Group (includes corresponding Graph/Chart)

US Plasma Industry Remains Highly Concentrated

Table 60. US Plasma Derivatives Market by Leading Suppliers (2015): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, and Others (includes corresponding Graph/Chart)

Tough Times Ahead for IVIG
Approved and Marketed Human Immunoglobulin Products in the US
Key Statistics

Table 61. US Market for Immunoglobulin by Leading Players (2014): Percentage Breakdown of Value Sales for Gammagard Liquid/Kiovig, Flebogamma/Gamunex, Privigen/Carimune NF, Octagam and Others (includes corresponding Graph/Chart)

Table 62. US Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Baxter Healthcare, CSL, Grifols, and Others (includes corresponding Graph/Chart)

Table 63. US Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales for Baxter, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)

Table 64. US Market for IVIg Products by Indication (2014 & 2020P): Percentage Breakdown of Volume Sales for CIDP, CLL, ITP, MMN, PID, and Other Neurological Diseases (includes corresponding Graph/Chart)

Table 65. US Specific Immunoglobulin Market by Product Type (2014): Percentage Breakdown of Value Sales for Anti-D, Anti-HB, Anti-T, and Rabies Immunoglobulin (includes corresponding Graph/Chart)

Table 66. US Specific Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Value Sales for Biotest, Cangene, CSL, Grifols, Kedrion, Sanofi (includes corresponding Graph/Chart)

Changing Supply Dynamics Alters Economics of Plasma Production

Table 67. Average Price per Gram of IVIg for Europe and US Markets (includes corresponding Graph/Chart)

Regulations Control Plasma Collection Industry
Key Statistics

Table 68. US Blood Bag (With Filters) Market (2014): Percentage Share Breakdown of Value Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)

Table 69. US Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)

Table 70. US Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, and Terumo (includes corresponding Graph/Chart)

Product Approvals/Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics
US Blood Components and Plasma Market Analyzed by Value Sales

Table 71. US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 72. US Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 73. US 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

US Blood Components and Plasma Market Analyzed by Consumption in Units

Table 74. US Recent Past, Current & Future Analysis for Blood Components and Plasma by Blood Components - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 75. US Historic Review for Blood Components and Plasma by Blood Components - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 76. US 14-Year Perspective for Blood Components and Plasma by Blood Components - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Current and Future Analysis
Canada Continues to Rely on Imports to Meet Demand for Blood Plasma
Bleeding Disorders – A Major Threat
'CSA-Z902-04' – A Comprehensive Voluntary Blood Safety Standard
Product Launches/Approvals
Strategic Corporate Developments
Canadian Blood Services – The Major Blood Bank
B. Market Analytics

Table 77. Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 78. Canadian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 79. Canadian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Current and Future Analysis
Japan Witnesses Surge in Imported Blood Products
Growing Market for Fresh Frozen Plasma
Growing Use of Imported Albumin Based Blood Products
The Goal of Self-Sufficiency
Graying Population to Drive Market Growth

Table 80. Japanese Elderly (65+ Years) Population for the Period 2000-2020 (includes corresponding Graph/Chart)

Strategic Corporate Development
Select Players
B. Market Analytics

Table 81. Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 82. Japanese Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 83. Japanese 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Current and Future Analysis
Market Trends and Issues
Legislations on Payment for Donation Restrict Donors
Government’s Check on Healthcare Costs Pressurizes BCT Manufacturers
Purchasing System Witnesses Modifications
Aging Population to Drive Demand for IVIg Products

Table 84. Aging Population in Europe by Geographic Region (2015E & 2020): Percentage of Elderly Individuals of Age 60 Years and Above Compared to Overall Population for Eastern Europe, Northern Europe, Southern Europe, and Western Europe (includes corresponding Graph/Chart)

Table 85. European Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales by Plasma Fractionators for Baxter Healthcare, Biotest, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)

Overview of Blood Banking Market
Competitive Scenario
Alpha 1 Market to Benefit from Growing Competition
Key Statistics

Table 86. European Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, MacoPharma, Terumo, and Others (includes corresponding Graph/Chart)

Table 87. European Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/ Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)

Challenges Exist in EU Blood and Blood Components Supply
Product Approvals
B. Market Analytics

Table 88. European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 89. European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 90. European 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

Table 91. European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 92. European Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 93. European 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

Table 94. European Recent Past, Current & Future Analysis for Blood Collection Devices by Type - Manual Blood Collection, Apheresis and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 95. European Historic Review for Blood Collection Devices by Type - Manual Blood Collection, Apheresis and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 96. European 14-Year Perspective for Blood Collection Devices by Type - Percentage Breakdown of Value Sales for Manual Blood Collection, Apheresis and Autologous Devices Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
Current and Future Analysis
Blood Collection and Transfusion Operations in France – An Overview
Strategic Corporate Development
Key Players
B. Market Analytics

Table 97. French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 98. French Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 99. French 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Current and Future Analysis
A Peek into German Blood Transfusion Organizational Set Up
Product Approvals/Launches
Select Players
B. Market Analytics

Table 100. German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 101. German Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 102. German 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Current and Future Analysis
Blood Transfusion Operational Structure in Italy – An Overview
Kedrion S. p. A. – A Leading Italian Player for Plasma Fractionation
B. Market Analytics

Table 103. Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 104. Italian Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 105. Italian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Current and Future Analysis
A Peek into UK Blood Transfusion Operations
Strategic Corporate Development
Bio Products Laboratory Ltd – A Leading UK Player for Plasma Fractionation
B. Market Analytics

Table 106. UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 107. UK Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 108. UK 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4E. SPAIN

A. Market Analysis
Current and Future Analysis
Blood Transfusion in Spain
Strategic Corporate Development
Grifols, S. A – A Leading Spanish Player for Plasma Fractionation
B. Market Analytics

Table 109. Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 110. Spanish Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 111. Spanish 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4F. RUSSIA

A. Market Analysis
Current and Future Analysis
Strategic Corporate Development
B. Market Analytics

Table 112. Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 113. Russian Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 114. Russian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Current and Future Analysis
Product Launches
Strategic Corporate Developments
Select Players
B. Market Analytics

Table 115. Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 116. Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 117. Rest of Europe 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis
ASEAN – Striding Towards Standardization of Blood Supply
B. Market Analytics

Table 118. Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 119. Asia-Pacific Historic Review for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 120. Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for China, and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

Table 121. Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 122. Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 123. Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis
A Key Market
Government Wakes Up to Realities

Table 124. Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart)

Table 125. Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female (includes corresponding Graph/Chart)

Table 126. Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, and 61-70 (includes corresponding Graph/Chart)

Overview of Chinese Blood Plasma Market
Availability of Plasma Proteins in the US and China (2015): A Comparison

Table 127. Chinese Plasma Products Market by Product Type (2015): Percentage Breakdown of Value Sales for Albumin, Hyper-immune, IVIg and Others (includes corresponding Graph/Chart)

Government Exercises Strict Control Over Production, Supply and Import of Plasma-based Products
Gap in Domestic Demand and Supply of Plasma Products Persists Despite Increasing Output

Table 128. Plasma Supply, Demand, and Deficit in Chinese Market: 2008-2015 (includes corresponding Graph/Chart)

Table 129. Rising Number of Plasma Collection Stations and Volume of Plasma Collection in China: 2018-2015 (includes corresponding Graph/Chart)

Comparison of Average Yields for Select Plasma Based Products in China and International Markets
Deregulation and Supply Crunch to Drive Up Retail Prices of Plasma-based Products
Expanding Medical Indications Holds Key to Boosting Market Growth
Comparison of USFDA and CFDA Approved Indications for Human Albumin Therapeutic Products
Comparison of USFDA and CFDA Approved Indications for Human IVIG Therapeutic Products
Competitive Landscape

Table 130. Chinese Plasma Collection Stations Market by Leading Players (2014): Percentage Breakdown of Stations Owned by China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)

Blood Plasma Product Portfolio of Major Domestic Players

Table 131. Chinese Plasma Collection Market by Leading Players (2014): Percentage Volume Breakdown of Plasma Collection for Anhui Tonglu, CBPO, Chengdu Rongsheng, Hualan Biological, Shanxi Kangbao, Sichuan Shuyang, and Others (includes corresponding Graph/Chart)

Albumin Market in China Gains Favor of both Global and Local Players

Table 132. Leading Players in the Chinese Albumin Market (2016): Percentage Breakdown of Approvals for Baxalta, CSL, Grifols and Others (includes corresponding Graph/Chart)

IVIG – Strong Opportunities Ahead
Domestic Players Rule IVIG Market

Table 133. Chinese IVIG (Intravenous Immunoglobulin) Products Market by Leading Players (2016): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)

Plasma Derived Factor VIII – Nascent but Hold Potential

Table 134. Chinese Coagulation Factor VIII Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), Greencross China, Hualan Biological, and Shanghai RAAS (includes corresponding Graph/Chart)

Other Key Statistics

Table 135. Chinese Hepatitis B Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Hunan Nanyue, Shenzhen Weiwu, Sichuan Yuanda Shuyang, and Others (includes corresponding Graph/Chart)

Table 136. Chinese Rabies Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Guangdong Shuanglin Bio-Pharmacy, Hualan Biological, Hunan Nanyue, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)

Table 137. Chinese Tetanus Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)

Table 138. Chinese Human PCC (Prothrombin Complex Concentrate) Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, and Others (includes corresponding Graph/Chart)

Table 139. Chinese Human Ig Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, and Sichuan Yuanda Shuyang Pharmaceutical (includes corresponding Graph/Chart)

Table 140. Chinese Human Fibrinogen Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, Jiangxi Boya Bio-Pharmaceutical, Shanghai RAAS, and Others (includes corresponding Graph/Chart)

Table 141. Chinese Plasma Collection Market by Leading Players (2014): Percentage Breakdown of Plasma Collection Volume for Anhui Tonglu, Chengdu Rongsheng Pharmaceutical, China Biologic (CBPO), Hualan Biological, Shanxi Kangbao Biological, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)

Table 142. Chinese Plasma Market by Leading Players (2014): Percentage Breakdown of Plasma Output Volume for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)

Table 143. Leading Companies in the Chinese Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius, Shanghai Kindly Enterprise Development Group, Terumo, WEGO and Others (includes corresponding Graph/Chart)

Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 144. Chinese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 145. Chinese Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 146. Chinese 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

5B. REST OF ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis
Plasma Fractionation in Southeast Asia – A Focus on Current and Planned Capabilities
Overview of Select Regional Markets
Australia
India
Indonesia
Korea
Strategic Corporate Developments
Bharat Serums And Vaccines Ltd. – A Leading Indian Player for Plasma Fractionation
B. Market Analytics

Table 147. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 148. Rest of Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 149. Rest of Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

6. LATIN AMERICA

A. Market Analysis
Current and Future Analysis

Table 150. Leading Companies in the Latin American Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius/Fenwal, Grifols, JP, Terumo and Others (includes corresponding Graph/Chart)

B. Market Analytics

Table 151. Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 152. Latin American Historic Review for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 153. Latin American 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for Brazil, and Rest of Latin America Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

Table 154. Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 155. Latin American Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 156. Latin American 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

6A. BRAZIL

Market Analysis

Table 157. Brazilian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 158. Brazilian Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 159. Brazilian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

6B. REST OF LATIN AMERICA

Market Analysis

Table 160. Rest of Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 161. Rest of Latin America Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 162. Rest of Latin America 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 163. Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 164. Rest of World Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 165. Rest of World 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 209 (including Divisions/Subsidiaries - 253)
The United States (117)
Canada (10)
Japan (12)
Europe (51)
  France (4)
  Germany (13)
  The United Kingdom (11)
  Italy (4)
  Spain (3)
  Rest of Europe (16)
Asia-Pacific (Excluding Japan) (59)
Middle East (1)
Latin America (1)
Africa (2)